NEOG
NEOG
NASDAQ · Health Care

Neogen Corp

$9.31
+0.38 (+4.26%)
Financial Highlights (FY 2026)
Revenue
918.60M
Net Income
-1,121,253,473
Gross Margin
47.1%
Profit Margin
-122.1%
Rev Growth
+19.3%
D/E Ratio
0.43
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 47.1% 47.1% 58.3% 58.3%
Operating Margin -118.6% -106.7% 15.7% 16.2%
Profit Margin -122.1% -116.0% 11.6% 12.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 918.60M 770.12M 855.36M 756.81M
Gross Profit 432.66M 362.73M 498.56M 441.12M
Operating Income -1,089,367,577 -821,957,427 134.03M 122.48M
Net Income -1,121,253,473 -846,016,201 98.99M 96.55M
Gross Margin 47.1% 47.1% 58.3% 58.3%
Operating Margin -118.6% -106.7% 15.7% 16.2%
Profit Margin -122.1% -116.0% 11.6% 12.8%
Rev Growth +19.3% +19.3% -2.9% +12.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 305.53M 305.53M 498.80M 403.07M
Total Equity 707.74M 707.74M 1.03B 1.23B
D/E Ratio 0.43 0.43 0.49 0.33
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -966,702,258 -769,925,507 210.94M 195.24M
Free Cash Flow 98.90M 73.84M